ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 20, 2025 ARS Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.52, ...
New York Magazine2dOpinion
Today’s Angry Democrats Are Not Tomorrow’s Tea Party of the Left
Grassroots fury among Democrats isn’t especially ideological and will likely focus more and more on the common enemy.
Summit rises as Cantor becomes latest to launch with a bullish view
Summit Therapeutics (SMMT) stock gains as Cantor Fitzgerald issues an Overweight rating highlighting the company's lead asset ...
Summit Therapeutics (SMMT) Gets a Buy from Cantor Fitzgerald
Summit Therapeutics (SMMT – Research Report) received a Buy rating and price target from Cantor Fitzgerald analyst Eric Schmidt FCA today.
The Data Is Clear: Democrats Face Their Own Tea Party Revolt
The intensity of the anger roiling the party is at a historic level, suggesting a breach between congressional Democrats and the party grassroots so severe that it could reshape the 2026 primary ...
JD Supra3d
Non-Compete Round Up- FTC, NLRB, California and Delaware
As we approach the end of the first quarter in 2025, we have seen notable developments in non-compete law over the last 12 months. As the ...